To answer these questions, and further investigate the mechanism of CD4-mediated tumor rejection, we used different bone marrow donor mice to obtain sets of chimera mice that allowed us to separate, at the cellular level, antigen presentation from IFNγ signaling occurrences. The gene discussed is CD4; the disease is neoplasm.